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IL-9-Deficient Mice Establish Fundamental Roles
for IL-9 in Pulmonary Mastocytosis and Goblet
Cell Hyperplasia but Not T Cell Development
(Renauld et al., 1990) and hematopoietic progenitors
(Bourette et al., 1992). Recently, IL-9 has been proposed
as a candidate gene for asthma based on the correlation
of mapping studies carried out in mice and on human
populations (Marsh et al., 1994; Nicolaides et al., 1997)
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Cambridge, CB2 2QH and its expression profile (Shimbara et al., 2000). How-
ever, the specific role played by IL-9 in this process is†Department of Pathology
University of Cambridge unclear. It is also noteworthy that IL-9 signaling is initi-
ated from a receptor complex that includes the IL-9Cambridge, CB2 1QP
United Kingdom receptor (IL-9R) chain (Renauld et al., 1992) and the
cytokine receptor common g-chain (gc), which is found
to be mutated in cases of human X-SCID. Thus, a deficit
in IL-9 signaling may contribute to this syndrome (DiSummary
Santo et al., 1995).
Overexpression of IL-9 in transgenic mice has high-Interleukin-9 is a cytokine produced by Th2 cells and
is a candidate gene for asthma and atopy. We have lighted that dysregulated expression of this cytokine
induces profound perturbations in multiple hematopoi-generated IL-9-deficient mice to delineate the specific
roles of IL-9 in Th2 responses. Using a pulmonary etic cell lineages resulting in a diverse phenotype. Thus,
ubiquitous expression of an IL-9 transgene has beengranuloma model, we have demonstrated a distinct
requirement for IL-9 in the rapid and robust generation shown to associate with lymphomagenesis, enhanced
immunoglobulin expression, expansion of B-1 lympho-of pulmonary goblet cell hyperplasia and mastocytosis
in response to lung challenge. In contrast, eosinophilia cyte subsets (Renauld et al., 1994; Vink et al., 1999),
mastocytosis, and parasitic worm expulsion (Faulknerand granuloma formation were not affected. IL-9 was
not required for T cell development or differentiation, et al., 1997, 1998). Furthermore, expression of IL-9 trans-
genes under the control of a lung-specific promoter ledthe generation of naive or antigen-driven antibody re-
sponses, or the expulsion of the intestinal parasitic to severe airway inflammation with infiltration of eosino-
phils and lymphocytes, mast cell hyperplasia, and in-nematode Nippostrongylus brasiliensis. Thus, deletion
of IL-9 manifests as a highly defined phenotype in Th2 creased subepithelial collagen deposition (Temann et
al., 1998). While these data demonstrate the potent na-responses modulating mucus production and mast
cell proliferation. ture of the response to IL-9, their complexity makes
interpretation difficult.
We have used gene targeting to generate a novelIntroduction
mouse line in which we have disrupted the expression
of IL-9. These mice have been analyzed to determineImmune responses associated with atopy and helminth
infection are distinguished by the generation of T helper potential roles for IL-9 in naive animals and in response
to antigenic challenge and nematode infection. Signifi-2 cells with their characteristic expression of cytokines
such as IL-4, IL-5, IL-9, and IL-13 (Finkelman et al., 1997; cantly, disruption of IL-9 expression did not have a
multifocal effect, as seen in the IL-9 overproducingWills-Karp, 1999). Consequently, considerable interest
has focused on the effector functions elicited by these transgenics. Instead, our data show that IL-9 is critical
for the rapid induction of pulmonary goblet cell hyper-cytokines, including IgE secretion, eosinophilia, and mu-
cus production (Sanderson, 1992; Foster et al., 1996; plasia and mastocytosis following lung challenge.
Cohn et al., 1997; Nicolaides et al., 1997; Emson et al.,
1998; McKenzie et al., 1998a, 1999). The genes encoding Results
IL-4, IL-5, IL-9, and IL-13 are closely linked on human
chromosome 5 and map to a cytokine gene cluster that Generation of IL-9-Deficient Mice
also includes IL-3 and granulocyte-macrophage-colony The targeting vector comprised a 59 arm of homology
stimulating factor (GM-CSF) (McKenzie et al., 1993; Fra- and a 39 arm of homology positioned either side of the
zer et al., 1997). These genes map to the syntenic region neomycin resistance cassette (Figure 1A). The resulting
of mouse chromosome 11, with the exception of the homologous recombination event occurred at a ratio of
IL-9 gene, which maps to mouse chromosome 13 (Mock 1 in 175 neomycin resistant clones. Genotyping of wild-
et al., 1990). type (IL-91/1), heterozygous (IL-91/2), and homozygous
IL-9 was first identified as a mouse T cell growth factor null (IL-92/2) mice is shown in Figure 1B. IL-9-deficient
(Van Snick et al., 1989), but using in vitro assay systems mice were healthy and displayed no overt phenotypic
it has also been demonstrated to modulate B cell matu- abnormalities. Analysis of the IL-9-deficient mice failed
ration (Petit-Frere et al., 1993; Vink et al., 1999) and to to detect IL-9 RNA transcripts from activated lympho-
promote proliferation and differentiation of mast cells cytes using reverse transcriptase-polymerase chain re-
action assays (Figure 1C), and enzyme-linked immuno-
sorbent assays also failed to identify IL-9 protein in‡ To whom correspondence should be addressed (e-mail: anm@
mrc-lmb.cam.ac.uk). supernatants from splenocyte cultures (Figure 1D). To
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Figure 1. Inactivation of the IL-9 Gene by Ho-
mologous Recombination
(A) The structure of the IL-9 locus, the tar-
geting vector, and the predicted homologous
recombination event are shown. NEO, neo-
mycin resistance cassette; TK, thymidine ki-
nase cassette; B, BamHI; E, EcoRI; and N,
NotI.
(B) Southern blotting of F2 tail genomic DNA.
The indicated probe detects a 7.8 kb BamHI
fragment in the wild-type IL-9 gene and a
1.83 kb fragment as a result of the correct
homologous recombination event.
(C) RT-PCR analysis of IL-9 expression.
Splenocytes were stimulated with plate-
bound anti-CD3 for 48 hr, RNA was prepared,
and PCR was performed. WT, wild-type.
(D) Analysis of IL-9 expression from spleno-
cytes. Spleen cells (2.5 3 106 per ml) were
stimulated with plate-bound anti-CD3 (1 mg/
ml), anti-CD28 (10 mg/ml), and IL-2 (5 ng/ml)
for 72 hr. Supernatants were analyzed by
ELISA. Data are representative of two repeat
experiments. ND, not detected; open bars,
wild-types; and filled bars, IL-92/2.
determine the in vivo roles of IL-9, we have assessed Antigen-Specific Cytokine and Antibody Responses
Are Normal in IL-9-Deficient Micethe immune responses of the IL-9-deficient animals to
We also assessed whether the absence of IL-9 woulda range of immunological challenges that normally pro-
alter the induction of antigen-specific systemic immunevoke a Th2 phenotype.
responses following immunization with antigen. IL-9-defi-
cient and wild-type mice were challenged with ovalbu-
min complexed with the adjuvant alum and their cytokineNaive Cytokine Levels, Th1 and Th2 Cell Development,
and immunoglobulin responses analyzed. Mesentericand Total Serum Immunoglobulin Production
lymph node cells from the immunized mice were restim-Are Normal in IL-9-Deficient Mice
ulated in vitro using either anti-CD3 or antigen and theirSince in vitro assays have demonstrated a role for IL-9
cytokine production determined. Polyclonal and anti-in T cell activation, we wished to address whether the
gen-driven cytokine responses from immunized IL-9-disruption of IL-9 expression in vivo would alter the
deficient mice were comparable to those produced bylevels of T cell cytokine production. Polyclonal stimula-
the wild-type control animals (Figure 3A). Similarly, anti-tion of mesenteric lymph node cells from naive animals
gen-specific immunoglobulin responses were also unal-with anti-CD3 demonstrated that IL-5, IL-10, and IFN-g
tered by the absence of IL-9 expression (Figure 3B).production was not altered by the absence of IL-9 (Fig-
Thus, despite reports that IL-9 can alter the in vitroure 2A). Similarly, when lymph node cells were cultured
differentiation of B cells and enhance total immunoglob-in vitro under conditions that promote differentiation of
ulin expression, we have been unable to demonstrate
Th1 or Th2 cells, no significant differences were ob-
a significant role for IL-9 in this process in vivo following
served in the generation of these lineages in the IL-9-
IL-9 gene disruption. Our data indicate that in the ab-
deficient or wild-type mice (Figure 2B). In keeping with sence of IL-9 compensatory pathways exist for the nor-
the unaltered expression of cytokines, the total serum mal development of immunoglobulin responses.
immunoglobulin isotype responses detected in the IL-
9-deficient mice were comparable to those in the wild-
type controls (Figure 2C). Furthermore, FACS analysis Goblet Cell Hyperplasia and Mastocytosis Is
of cell suspensions prepared from lymph node, spleen, Severely Impaired in IL-9-Deficient Animals
bone marrow, peritoneum, and thymus, from naive IL- following the Induction of Synchronous
9-deficient and wild-type mice, demonstrated no differ- Pulmonary Granuloma Formation
ences in the expression of the following cell surface To determine the in vivo contribution of IL-9 in a Th2
markers: CD4, CD8, T cell receptor, CD3, CD5, CD25, cytokine-mediated inflammatory response, we em-
CD45, Gr-1 on thymocytes; CD4, CD8, T cell receptor, ployed a model system in which synchronous pulmonary
CD3, CD5, CD14, CD23, CD45, Gr-1, CD11b, TER119 granuloma formation is induced around Schistosoma
on mesenteric lymph node cells or splenocytes; CD3, mansoni eggs (Warren and Domingo, 1970). In this
CD5, CD14, CD23, CD24, CD43, CD45, Gr-1, CD11b, model, a cellular granulomatous response develops
TER119, BP1, c-kit on bone marrow; CD5, CD45, CD11b, around parasite eggs that lodge in the lungs following
their intravenous injection into mice. This inflammatoryc-kit, Gr-1 on peritoneal lavage (data not shown).
IL-9-Deficient Mice
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Figure 2. Analysis of Naive Immune Responses
(A) Polyclonal activation of mesenteric lymph node (MLN) cells. MLN
cells were stimulated with plate-bound anti-CD3 for the times
shown. Data represent means plus SD of triplicate wells. IL-4 was
below the levels of detection.
(B) Cytokine production following in vitro Th cell differentiation. Data
represent means plus SD of triplicate wells.
(C) Total serum immunoglobulin isotype production. Sera from three
animals were pooled. Data represent means plus SD of triplicate
wells. All data are representative of two repeat experiments. Open
bars, wild-types; and filled bars, IL-92/2.
Figure 3. Antigen-Specific Response of IL-9-Deficient and Wild-
response is characterized by the high-level expression Type Mice to Ovalbumin Immunization
of Th2 cytokines (Wynn et al., 1993), eosinophil infiltra- (A) Cytokine responses. Open bars, wild-types; and filled bars,
tion (McKenzie et al., 1999), and goblet cell hyperplasia. IL-92/2.
(B) Immunoglobulin responses. Cohorts of four to five animals wereThis model also has the advantage of generating an
immunized intraperitoneally with ovalbumin. Serum samples wereinflammatory response that can be quantified following
assayed by ELISA for immunoglobulin isotypes. Data are presentedeither a primary or secondary exposure to antigen (Mc-
as means plus SD. Representative data from two repeat experiments
Kenzie et al., 1999; Townsend et al., 2000). are shown. Open circles, immunized wild-types; filled circles, immu-
Significantly, following primary lung challenge, histo- nized IL-92/2; open square, naive wild-types; and filled square, naive
logical analysis demonstrated that in contrast to the IL-92/2.
wild-type controls, the IL-9-deficient animals failed to
develop the goblet cell hyperplasia normally found along
the airway epithelia (Figure 4A). Quantification of the also demonstrated fewer positive cells in the IL-9-defi-
cient mice (wild-type, 6.5 6 SE 0.329; IL-92/2, 2.672 6goblet cells demonstrated that 10-fold fewer goblet cells
were induced in the absence of IL-9 expression (Figure SE 0.321 [P 5 0.0004 by Student’s t-test], defined as
positive cells per 40 field of view). In contrast, we found4B). IL-9-deficient mice also failed to develop the masto-
cytosis evident in the lungs of the immunized wild-type no evidence for a decrease in the numbers of bone
marrow mast cells in the IL-9-deficient animals, as deter-mice. Enumeration of toluidine stained mast cells indi-
cated that lungs from IL-9-deficient mice contained mined by c-kit staining (wild-type, 13.4–15.01%; IL-92/2,
11.96–15.89%; defined as percentage c-kit positive cells8-fold fewer mast cells than the wild-type controls (Figure
4C). Furthermore, enumeration of pulmonary intraepi- of total bone marrow cells gating out erythrocytes).
Moreover, in vitro mast cell cultures generated from thethelial mast cells using chloroacetate esterase staining
Immunity
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bone marrow cells of wild-type and IL-9-deficient mice,
cultured in the presence of IL-3 and stem cell factor
(McKenzie et al., 1998b), also displayed equivalent mast
cell development (data not shown). These data indicate
that the deficit in mast cell expansion observed in the
IL-9-deficient lung tissue does not result from the ineffi-
cient generation of mast cell precursors but probably
reflects a defect in the proliferation of differentiated
cells.
To determine whether the differences observed in the
goblet cell hyperplasia were simply due to a decrease
in pulmonary inflammation, we analyzed the composi-
tion of the granulomas and lung tissue. We observed that
both the IL-9-deficient and wild-type animals developed
granulomas of equivalent size and cellularity (Figures
5A and 5B), with eosinophils constituting z30% of the
granuloma (Figure 5C). Furthermore, analysis of lung
tissue and bronchoalveolar lavage (BAL) showed no dif-
ference in the inflammatory response. Pulmonary fibro-
sis as assessed by collagen deposition was equivalent
in the two mouse lines (Figure 5D), as were the propor-
tions of eosinophils, neutrophils, macrophages, and
lymphocytes in the BAL fluid (Figure 5E). In addition, we
also analyzed the levels of the cellular adhesion mole-
cules ICAM-1 (CD54) and VCAM-1 (CD106), which are
normally associated with inflammatory processes (Bevi-
lacqua, 1993). Histological examination of lung tissue
from immunized IL-9-deficient and wild-type animals dem-
onstrated equivalent staining for ICAM-1 and VCAM-1
(Figure 5F) as determined using the arbitrary scoring
system outlined in Experimental Procedures. Since IL-4,
IL-5, and IL-13 have been shown to play important roles
in the development of pulmonary Th2 responses, we
assessed the expression of these cytokines from cul-
tures prepared from the draining mediastinal lymph
nodes of wild-type and IL-9-deficient mice following pri-
mary immunization. Significantly, we found equivalent
antigen-induced expression of IL-4, IL-5, and IL-13 by
the wild-type and IL-9-deficient mice (Figure 5G). Thus,
the observed reduction in goblet cell and mast cell num-
bers in the IL-9-deficient mice occurs independently of
these cytokines, indicating that IL-9 is a key regulator
of these processes. Moreover, these data also indicate
that the induction of IL-4, IL-5, and IL-13 is not regulated
by IL-9.
Previous studies using cytokine-deficient mice have
demonstrated that IL-4 and IL-5 do not play an essential
role in Th2 cell driven pulmonary mucus production
Figure 4. Goblet Cell Hyperplasia and Mastocytosis during the Pri- (Cohn et al., 1997, 1999). However, IL-4Ra, a shared
mary Pulmonary Inflammatory Response
component of the IL-13 receptor complex, is critical for
(A) Histological analysis of goblet cells in wild-type and IL-92/2 lung. this process (Cohn et al., 1999), implying a role for IL-
Lung sections were stained with PAS. Wild-type image demon-
13 in the regulation of goblet cells. IL-13 has also beenstrates epithelial goblet cell hyperplasia (stained red) around an
reported to act in the generation of goblet cell responsesairway adjacent to cellular infiltrate induced by an entrapped egg.
(Grunig et al., 1998; McKenzie et al., 1998a; Wills-KarpDespite similar cellular infiltration, goblet cell hyperplasia is not
evident in the section from the IL-9-deficient sample. Magnification, et al., 1998). In order to investigate the interaction of IL-
320. 13 and IL-9 in the regulation of goblet cell hyperplasia,
(B) Determination of goblet cell number. Enumeration of PAS posi- we have assessed primary granuloma formation in IL-
tive goblet cell numbers to give mucus cell score. Data are presented 13-deficient mice. In marked contrast to the specific
as means plus SE.
reduction in goblet cell responses observed in IL-9-defi-(C) Toluidine blue stained mast cell numbers from wild-type and IL-
cient animals, IL-13-deficient animals developed a glo-9-deficient mice. Data are presented as means plus SE.
bal impairment in their Th2 response with a concomitantAll data are representative of three repeat experiments using four
to six mice per group. Open bars, wild-types; and filled bars, reduction in granuloma volume (Figure 6A), 3-fold fewer
IL-92/2 . goblet cells (Figure 6B), a reduction in eosinophilia (Fig-
ure 6C) and fibrosis (Figure 6D), and reduced levels of
IL-9-Deficient Mice
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IL-4, IL-5, and to a lesser extent IL-9 (Figure 6E). Thus,
both IL-9 and IL-13 can regulate goblet cell hyperplasia.
Critically, since in the IL-9-deficient mice IL-13 was ex-
pressed normally but could not compensate for the lack
of IL-9 in the primary response, this highlights an impor-
tant primary role for IL-9 in the initiation of the goblet cell
response. Thus, the primary pulmonary granulomatous
model demonstrates that although mice deficient in IL-9
are still capable of mounting an eosinophil-rich Th2-
mediated inflammatory response, they fail to generate
the normal goblet cell hyperplasia and mastocytosis
associated with primary lung challenge. It is noteworthy
that following secondary challenge the pulmonary gran-
ulomatous response produces an equivalent induction
of goblet and mast cells even in the absence of IL-9
expression (data not shown). These data demonstrate
that the role of IL-9 in this response is an early event
and that further compensatory factors can modulate the
goblet cell response following priming.
Responses to the Parasitic Nematode N. brasiliensis
Are Normal in IL-9-Deficient Mice
Immunological responses to gastrointestinal parasitic
worm infections are also characterized by the expres-
sion of Th2 cytokines (Finkelman et al., 1997). A potential
role for IL-9 in the expulsion of parasitic nematodes
has been suggested by the expression profile of this
cytokine during infections and by the extremely rapid
expulsion of parasites by IL-9-overexpressing trans-
genic mice (Faulkner et al., 1997, 1998). Using N. bra-
siliensis as a model, we have infected the IL-9-deficient
mice and compared worm expulsion with that of wild-
type mice. The wild-type and IL-9-deficient mice dis-
played very similar worm burdens at day 5 postinfection
(p.i.), and both groups had expelled their worms com-
pletely by day 10 p.i. (Figure 7A). However, we found
reproducibly fewer goblet cells in the intestines of the
IL-9-deficient mice than the wild-types (Figure 7B). We
also assessed intestinal mast cells associated with N.
brasiliensis infection. Intraepithelial mast cells were de-
tected on sections of jejunum from infected mice, by
staining with toluidine blue or using cytochemical stain-
ing of sections to detect chloroacetate esterase activity
crogram of collagen per milligram of protein. Data are presented as
means plus SE.
(E) Determination of bronchoalveolar lavage (BAL) cell composition.
Cytocentrifuge preparations of BAL cells were stained with Giemsa
and differential counts performed. Eos, eosinophils; neut, neutro-
Figure 5. Granuloma Formation and Eosinophilia during the Primary phils; mac, macrophages; and lymph, lymphocytes. Data are pre-
Pulmonary Inflammatory Response sented as means plus SE.
(A) Morphological analysis of granuloma formation in wild-type and (F) Histological analysis of ICAM-1 (top panels) and VCAM-1 (bottom
IL-92/2 mice. Lung sections were stained with haematoxylin and panels) expression in the alveolar parenchyma of primary challenged
eosin. Magnification, 320. wild-type and IL-92/2 mice. Magnification, 340. Expression of
(B) Determination of granuloma volumes in immunized mice. Lung ICAM-1 and VCAM-1 (stained brown) was evaluated double-blind
sections were stained with haematoxylin and eosin, and at least using an arbitrary scoring system.
100 individual granulomas were measured per group. Data are pre- (G) Cytokine responses from activated lymph node cells. Draining
sented as means less egg volumes plus SE. mediastinal lymph node cells were cultured for 4 days with soluble
(C) Determination of granuloma eosinophils. The percentage eosino- egg antigen. Supernatants were analyzed by cytokine ELISA. Data
phils per granuloma was determined from lung sections, and at are presented as means plus SE.
least 100 individual granulomas were examined per group. Data are Cohorts of four to six mice were injected intravenously with 5000
presented as means plus SE. schistosome eggs to induce synchronous pulmonary granuloma.
(D) Determination of pulmonary fibrosis. Pulmonary collagen was Mice were killed 14 days later. Data are representative of two repeat
quantified by differential staining of sections and expressed as mi- experiments. Open bars, wild-type; and filled bars, IL-92/2.
Immunity
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Figure 6. Analysis of Primary Pulmonary In-
flammatory Response in IL-132/2 Mice
(A) Determination of granuloma volumes in
immunized wild-type and IL-132/2 mice. Lung
sections were stained with haematoxylin and
eosin, and at least 100 individual granulomas
were measured per group. Data are pre-
sented as means less egg volumes plus SD.
(B) Determination of goblet cell number in
wild-type and IL-132/2 lung. Lung sections
were stained with PAS, and goblet cell num-
bers were counted to give mucus cell score.
(C) Determination of granuloma eosinophils.
The percentage eosinophils per granuloma
was determined from lung sections, and at
least 100 individual granulomas were exam-
ined per group. Data are presented as means
plus SD.
(D) Determination of pulmonary fibrosis. Pul-
monary collagen was quantified by differen-
tial staining of sections and expressed as mi-
crogram of collagen per milligram of protein.
Data are presented as means plus SD.
(E) Cytokine responses from activated lymph
node cells. Draining mediastinal lymph node
cells were cultured for 4 days with soluble
schistosome egg antigen. Supernatants were
assayed for cytokines by ELISA. Data are pre-
sented as means plus SD.
Cohorts of four mice were injected intrave-
nously with 5000 schistosome eggs to induce
synchronous pulmonary granuloma as de-
scribed above. Data are representative of two
repeat experiments. Open bars, wild-types;
filled bars, IL-132/2.
present in all mouse mast cells (Friend et al., 1996). more antigen-specific Th2 cytokines (Figure 7E), possi-
bly indicating a requirement for compensation in theseAlthough we observed a general trend of fewer intraepi-
thelial mast cells in IL-9 deficient mice compared to animals.
wild-type mice, the differences were not statistically sig-
nificant. For example, at day 10 postinfection wild type Discussion
mice (n 5 5) had 4.42 6 0.57 esterase positive mast
cells per villus crypt unit (mean 6 SE) whereas IL-9- In order to investigate the in vivo roles of IL-9, we have
generated a novel line of IL-9-deficient mice. The im-deficient mice (n 5 4) had 2.94 6 0.52 mast cells per
villus crypt (p , 0.11 by Student’s t-test). Previously, it mune functions of these animals have been evaluated
both in naive mice and in animals following immunizationhas been shown that mice overexpressing IL-9 have
marked mast cell infiltration of the muscularis mucosa or infection. These studies have highlighted an impor-
tant role for IL-9 in the rapid and robust generation of(Godfraind et al., 1998). To more accurately determine
the full extent of intestinal mastocytosis in nematode- pulmonary goblet cell hyperplasia and mastocytosis.
However, our studies have failed to show a significantinfected mice, we measured the levels of mast cell prote-
ases (mMCP-1) in homogenates of jejunum from in- role for IL-9 in T cell development or differentiation, the
generation of naive or antigen-driven antibody re-fected mice. Throughout the course of infection with N.
brasiliensis, mMCP-1 activity in the jejunum was lower sponses, or the expulsion of the intestinal parasitic nem-
atode N. brasiliensis.in IL-9 deficient mice compared to wild type mice (Figure
7C). It is appropriate to highlight that in separate nema- Despite reports that IL-9 can act as a growth factor
for certain T cell clones (Van Snick et al., 1989) andtode infection studies, although we have consistently
observed reduced intestinal mastocytosis in IL-9 defi- the observed development of thymic lymphomas in IL-9
transgenic mice (Renauld et al., 1994), we were unablecient mice, based on two different mast cell histological
stains and detection of mast cell protease activity, these to identify changes in the T cell subpopulations of the
thymus or peripheral lymphoid tissues from the IL-9-differences have not been statistically significant. Anti-
gen-specific antibody responses following infection deficient mice. Thus, if IL-9 does play a role in T cell
development, alternative pathways must function in itswere also comparable between the two groups (data
not shown). Polyclonal and antigen-specific cytokine absence. This represents an important finding, since
IL-9 binds to a receptor complex that includes the IL-9Rproduction from the mesenteric lymph node cells of the
IL-9-deficient and wild-type mice indicate comparable and gc, and it has been suggested that IL-9 may repre-
sent an additional signal that is missing in human pa-cytokine responses at day 5 p.i. (Figure 7D) but suggest
that by day 10 p.i. the IL-9-deficient mice are making tients suffering from X-SCID, which is caused by muta-
IL-9-Deficient Mice
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Figure 7. Infection with Nippostronglyus bra-
siliensis
(A) Infected mice were sacrificed at the times
indicated to obtain intestinal worm counts.
Data are representative of two repeat experi-
ments. Open bars, wild-types; filled bars, IL-
92/2; and ND, not detected.
(B) Determination of goblet cell number. Enu-
meration of PAS positive goblet cells per vil-
lus crypt unit (VCU). Data are presented as
means plus SE with p value (Student’s t-test).
(C) Mouse mast cell protease-1 (mMCP-1) ac-
tivity was measured from jejunal homoge-
nates. Data are presented as means plus SE
with p value (Student’s t-test).
(D) Cytokines at day 5 postinfection. Mesen-
teric lymph node cells from wild-type and
IL-92/2 animals following infection with N.
brasiliensis were stimulated with anti-CD3 or
N. brasiliensis antigen (NbES). Supernatants
were analyzed by cytokine ELISA. Data are
presented as means plus SD.
(E) Cytokines at day 10 postinfection. Mesen-
teric lymph node cells were stimulated as de-
scribed for day 5. Data are presented as
means plus SD.
Cohorts of five mice were infected with 500
viable third stage N. brasiliensis larvae. Data
are representative of two repeat experiments.
Open bars, wild-types; and filled bars, IL-92/2.
tions in the gc gene (Di Santo et al., 1995). However, it will whether such B-1 cell populations become evident fol-
lowing various antigenic challenges or when IL-9 dele-be interesting to determine whether an additive effect of
IL-9 in T cell development may be found by intercrossing tion is performed in combination with the disruption of
IL-5.the IL-9-deficient mice with other mouse lines deficient
in the expression of cytokines that utilize gc, for example Using the pulmonary granuloma model, we have been
able to study the onset of Th2 responses during bothIL-2, IL-4, IL-7, and IL-15.
We have also found that immunoglobulin responses primary and secondary challenges in order to identify
obligate roles for IL-9 in these immune responses. Thisare unaltered by the absence of IL-9. These data differ
from those reported for the IL-9 transgenic mice that approach has proved highly illuminating, identifying that
IL-9 is critically important for the rapid onset of gobletdisplay a global increase in all immunoglobulin isotypes
(Vink et al., 1999). While it is not clear why this should cell hyperplasia and the upregulation of mast cells but
not for eosinophilia, fibrosis, or lymphocyte function.be the case, it seems likely that aberrant overexpression
of IL-9 induces indirect upregulation of B cell function, Th2 cell-mediated mucus production represents an
important response for protecting mucosal surfaces. Al-which does not represent a critical role for IL-9. To date,
we have also failed to demonstrate any change in the though mucus production acts positively in the protec-
tion of mucosal surfaces from pathogens and by as-number of peritoneal B-1 cells in the IL-9-deficient mice.
These data also contrast with the findings from IL-9 sisting in parasite expulsion (Nawa et al., 1994), it may
also be detrimental by contributing to airway obstructiontransgenic mice that display an expansion of a B-1 lym-
phocyte population that is independent of IL-5 regula- during pulmonary inflammatory responses (Rogers, 1994).
The regulation of goblet cell mucus production by cyto-tion (Vink et al., 1999). It seems likely that the IL-9-
responsive population of B-1 cells represents only a kines has been attributed to IL-4, IL-9, and IL-13. While
IL-4 is presumed to be necessary for the generation ofsmall proportion of cells in naive mice, making changes
in this subset difficult to identify and only following ex- IL-9 and IL-13 producing Th2 cells (Cohn et al., 1999),
IL-9 and IL-13 are believed to directly regulate goblettensive overexpression of IL-9 do they become appar-
ent. Further analysis will be necessary to examine cell production and function (Grunig et al., 1998; McKen-
Immunity
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zie et al., 1998a; Wills-Karp et al., 1998; Cohn et al., tures, IL-9 does not appear to effect mast cell progenitor
1999; Louahed et al., 2000). Our data from IL-9-deficient production but apparently enhances mast cell expan-
mice now demonstrate that IL-9 is a critical factor for sion in the lung tissue. These data contrast with those
initiating the primary goblet cell response following pri- reported for IL-3-deficient mice in which impaired mast
mary pulmonary challenge. Significantly, this regulation cell outgrowth results from a defect in mast cell progeni-
of goblet cell hyperplasia is independent of IL-13, IL-4, tor development (Lantz et al., 1998). Interestingly, we
and IL-5. Moreover, IL-9-deficient mice developed oth- also observed that prolonged in vivo exposure to anti-
erwise normal pulmonary Th2 inflammatory responses gen, in the form of a secondary immunization, overrides
with characteristic eosinophilia, ICAM-1 and VCAM-1 the dependence on IL-9, and other factors can then
expression, fibrosis, and BAL cell composition, indicat- compensate for the role of IL-9 in mastocytosis. Cer-
ing that the goblet cell defect is not due to a diminution tainly stem cell factor, IL-3, and IL-4 are all capable of
of the inflammatory response but is specific to the deficit inducing mast cell outgrowth (Galli and Hammel, 1994).
in IL-9 expression. Despite our observations in the lung demonstrating
There is obvious complexity to the interrelated roles of that IL-9 plays a significant role in modulating the im-
IL-9 and IL-13 in the regulation of goblet cell production. mune response to antigen, we have been unable to
Clearly, IL-13 expression in the primary challenge is nor- determine an essential role for IL-9 in the expulsion of
mal yet fails to compensate for the absence of IL-9. the parasitic nematode worm N. brasiliensis. Although
Therefore, IL-9 must act independently of IL-13 in initiat- we observed fewer goblet cells in the IL-9-deficient
ing this response. However, it is apparent that IL-13 is mice, parasite expulsion was not delayed by the ab-
also an important factor in the regulation of goblet cell sence of IL-9. However, we did observe an increase in
responses. It is possible that IL-13 may perform a role IL-4 and IL-5 production by restimulated cells from the
as a goblet cell-enhancing factor acting independently mesenteric lymph node of IL-9-deficient mice. This may
of IL-9 and with slower kinetics or that it is necessary indicate that the disruption of IL-9 expression alters
for developing the Th2 response and increasing IL-9 the balance of the normal response necessitating an
expression. Our experiments using IL-13-deficient mice increase in the expression of other Th2 cytokines, which
indicate that in the absence of IL-13, goblet cell hyper- then compensate for the loss of IL-9. Although studies
plasia is also impaired though to a lesser degree than in have shown that IL-9 transgenic mice expel nematode
the IL-9-deficient mice. In contrast to the IL-9-deficient parasite infections more efficiently than wild-type ani-
mice, the IL-13-deficient mice also develop a global mals, the physiological significance of these findings
downregulation of the Th2 response with smaller granu- is unclear since naive IL-9 transgenic mice display a
lomas, a reduction in eosinophilia and fibrosis, and re- severely altered immune system. However, it is possible
duced levels of IL-4, IL-5, and IL-9. The normal levels that analysis of other parasitic worm models, which vary
of goblet cells induced following secondary challenge in their modes of colonisation, may uncover a mecha-
of the IL-9-deficient mice indicate that alternative IL-9- nism that is hidden in the N. brasiliensis model.
independent mechanisms can compensate for the ab- In conclusion, our data have highlighted an important
sence of IL-9 following sensitization. Future studies will role for IL-9 in the rapid onset of goblet cell hyperplasia
address the interrelated role of IL-13 in this process. and mastocytosis in a pulmonary Th2 response. These
Our results demonstrating a key role for IL-9 in mucus results may have important consequences in the fields
production are supported by a study of allergen-chal- of asthma and allergy, and these mice should prove an
lenged dogs in which IL-9, but not IL-5 or IL-13, was important resource for the evaluation of IL-9 function in
found to be the only cytokine that correlated with mucus models of airway hyperresponsiveness. The transient
production. The authors further showed that epithelial nature of the observed defect in goblet cell hyperplasia
cells express IL-9R and that tracheal administration of and mastocytosis also emphasises the complex nature
IL-9 enhanced goblet cell number (Longphre et al.,
of the cytokine response and its capacity for compen-
1999). Furthermore, Louahed et al. (2000) have demon-
sation. Future studies will attempt to address the inter-
strated that IL-9 and IL-13 can independently regulate
related roles of the Th2 cytokines using intercrossingmucin gene expression following treatment of mice or
of cytokine-deficient and cytokine-transgenic mice toculture of human pulmonary epithelial cells.
probe the causal relationships involved in these re-Elevated numbers of mast cells are characteristic of
sponses.Th2 responses, being produced in response to helminth
infection, and are thought to contribute to the pathology
Experimental Proceduresof pulmonary disease by releasing vasoactive mediators
that exacerbate inflammation following IgE-cross-link-
Targeted Disruption of the Mouse IL-9 Gene in Embryonic
ing (Costa et al., 1997). Both in vitro and in vivo studies Stem Cells
have indicated that IL-9 plays a contributory role in the The replacement vector was constructed to insert the neomycin
generation of mast cells (Renauld et al., 1990; Faulkner resistance gene into exon 4 of the IL-9 gene deleting the nucleotides
et al., 1997; Godfraind et al., 1998; Temann et al., 1998). encoding amino acids 54–59. Stop codons in all three frames were
inserted 59 of the selectable marker. The targeting vector consistedOur study supports these findings, indicating that in the
of 1.8 kb of the IL-9 gene providing the 59 arm of homology andabsence of IL-9 the normal increase in mast cell number
3.8 kb comprising the 39 homology arm. The targeting vector wasfollowing lung challenge is severely curtailed. Thus, IL-9
linearized and electroporated into E14.1 embryonic stem (ES) cells
appears to be important for the rapid generation of mast (McKenzie et al., 1998b). Of 700 G418 resistant clones screened by
cells following antigen challenge. Since we observed no Southern analysis, using an external flanking probe, four were found
deficit in the generation of bone marrow mast cells or to be targeted correctly. Hybridization with a probe to the neomycin
sequence confirmed the predicted size of the targeted fragmentthe outgrowth of mast cells from bone marrow cell cul-
IL-9-Deficient Mice
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and that only a single integration had occurred. The targeted ES Secondary synchronous pulmonary granulomas were induced as
follows. Mice were sensitised to schistosome eggs by intraperito-cell clone was microinjected into 3.5 day C57BL/6 blastocysts to
generate chimeras. These mice were mated with C57BL/6 mice neal injection of 5000 eggs. Fourteen days later, sensitized mice,
four to six mice per group, were injected intravenously with 5000and transmitted the ES cell genotype through the germline. Mice
homozygous for the disrupted IL-9 gene were obtained by inter- eggs to induce synchronous pulmonary granulomas. Fourteen days
after intravenous egg injection, mice were sacrificed and the drain-breeding the heterozygotes. IL-13-deficient mice were those gener-
ated as described previously (McKenzie et al., 1998a). The IL-9 gene- ing mediastinal lymph nodes were removed. The lungs were pro-
cessed for histology as described above.targeted, IL-13 gene targeted, and wild-type animals used in the
experiments reported below were maintained on a 129 3 C57BL/6
(F2) background in a specific pathogen free environment.
Immunocytochemical Detection of ICAM-1 and VCAM-1
Lung tissue was removed, snap frozen, and cryosectioned. Antibod-
Stimulation of Naive Lymphocytes and RNA Preparation ies for detection of ICAM-1 and VCAM-1 were purchased from Phar-
Mesenteric lymph node cells or splenocytes from three animals Mingen (San Diego, CA, USA). Immunocytochemistry to detect
were pooled and cultured at 2.5 3 106 cells per ml on plates coated ICAM-1 and VCAM-1 expression was performed essentially follow-
with anti-CD3. Total RNA was prepared using RNAzolB. RT-PCR ing the manufacturer’s instructions. Sections were incubated with
primers for IL-9 were 59-AGACACCATGGACCTTATTTAAAATCT Hamster IgG anti-mouse ICAM-1 (Clone 3E2), Hamster IgG standard
GAAGG-39 and 59-GGACACGTTATGTTCTTTAGG-39. The internal (clone A19-3), Rat IgG2a anti-mouse VCAM-1 (Clone 429[MVCAM
oligonucleotide used for hybridization was 59-CTGCTTGTGTCT A]), and purified Rat IgG2a (clone R35-98). Bound antibodies were
CTCCGTCCC-39. HPRT primers and conditions were as described detected by incubation with biotinylated anti-hamster IgG (clones
in Reiner et al. (1993). G70-204, G94-56) and anti-Rat IgG1/2a (clone G28-5). Sections were
probed with streptavidin-peroxidase (StrepABC/Complex/HRP kit,
In Vitro T Helper Cell Differentiation Assays Dako AS, Glostrup, Denmark) according to the manufacturer’s in-
Mesenteric lymph node cells were cultured on anti-CD3e antibody- structions. 3,39-Diaminobenzidine was used as substrate, and sec-
coated plates (1 mg/ml of clone 2C11, Becton Dickinson) in the tions were counterstained with haematoxylin. Expression of ICAM-1
presence of exogenous cytokines or anti-cytokine antibody as indi- and VCAM-1 was evaluated double-blind using an arbitrary scoring
cated. IL-2 (10 ng/ml, R&D) was added to all cultures. Th2 cell system. 0, background staining comparable to irrelevant control
differentiation was promoted in the presence of 100 ng/ml IL-4 antibody; 1, weak sporadic staining; 11, unequivocal staining; and
(R&D) and anti-IFNg antibody (10 mg/ml of clone XMG1.2, Becton 111, unequivocal strong staining.
Dickinson), while Th1 differentiation was promoted by anti-IL-4 anti-
body at 10 mg/ml (clone 11B11, DNAX Research Institute) and IL-
Immunization with Ovalbumin Protein Antigen12 (1 ng/ml, Genzyme, West Malling, UK). Cells were cultured for 5
Mice were immunized intraperitoneally with 100 mg of ovalbumin/days, washed, and resuspended at 1 3 106 cells per ml for 24 hr in
alum. At day 10, 20, and 30, these animals were administered intra-the presence of plate-bound anti-CD3. Supernatants were analyzed
peritoneally with 50 mg of ovalbumin/alum. After a further 10 days,by cytokine ELISA.
mesenteric lymph node cells were prepared and cultured at 4 3 106
cells per ml in the presence of ovalbumin (25 mg/ml) for 5 days, orPulmonary Granuloma Formation
cultured at 2 3 106 cells per ml in the presence of anti-CD3 for upPrimary synchronous pulmonary granulomas were induced by intra-
to 4 days. Anti-IL-4Ra antibody (Genzyme) at 0.5 mg/ml was addedvenous injection of mice with S. mansoni eggs (Warren and Do-
for the final 24 hr of culture. Supernatants were analyzed for cyto-mingo, 1970). S. mansoni eggs were isolated from the livers of in-
kines using ELISA. Serum samples were assayed for ovalbuminfected mice as described (Fallon et al., 1998). Fourteen days after
antigen-specific immunoglobulin isotypes as detailed below.intravenous egg injection, mice were sacrificed and the lungs were
inflated with formal saline (10% formaldehyde in saline) and pro-
cessed for histology. The horizontal and perpendicular diameters Antigen-Specific Antibody ELISA
of the granulomas surrounding individual eggs were measured with With the exception of antigen-specific IgE, ovalbumin-specific iso-
an ocular micrometer. All sections were measured by the same type responses were measured using ELISA by coating 96-well
individual using a blind protocol. The volume of the egg granuloma plates with ovalbumin at 5 mg/ml; bound immunoglobulin of diluted
was calculated assuming a spherical shape. .100 individual granu- serum samples was detected using biotinylated monoclonal antiim-
lomas were analyzed per group. Goblet cells were counted on Peri- munoglobulin isotype detection antibodies (Becton Dickinson).
odic Acid-Schiff (PAS)-stained lung sections using an arbitrary scor- Ovalbumin-specific serum IgE was determined using a two-step
ing system, as described (Grunig et al., 1998). PAS-stained goblet sandwich ELISA based on the method of van Halteren et al. (1997).
cells in airway epithelium were measured double-blind using a nu- ELISA plates were coated at 2 mg/ml with a monoclonal anti-mouse
merical scoring system (0: ,5% goblet cells; 1: 5 to 25%; 2: 25 to IgE antibody (Pharmingen clone R35-72). Serum samples were
50%; 3: 50 to 75%; 4: .75%) The sum of airway scores from each added and the plates incubated for 1 hr at room temperature. After
lung was divided by the number of airways examined, 20–50 airways washing, digoxigenin-coupled ovalbumin (DIG-OVA), prepared from
per mouse, and expressed as mucus cell score in arbitrary units (U). a kit containing digoxigenin-3-O-methylcarbonyl-e-amonocaproic
Granuloma eosinophil infiltration was counted on Giemsa stained acid N-hydroxy-succinimide ester (Boehringer Mannheim GmbH,
sections, and the numbers of eosinophils expressed as a percentage Mannheim, Germany), was added and incubated for 1 hr at room
of the cell composition of the granuloma. Pulmonary collagen was temperature. After washing, anti-digoxigenin-Fab fragments cou-
quantified by differential staining of sections and expressed as mi- pled to peroxidase (Boehringer Mannheim GmbH, Mannheim, Ger-
crogram of collagen per milligram of protein (Fallon and Dunne, many) were used to detect bound antibody.
1999). Toluidine blue stained mast cells were enumerated by count-
ing the number of positively stained cells per 310 field of view with
20 fields per mouse (Miller et al., 1994). Chloroacetate esterase Helminth Infection
Individual mice were inoculated subcutaneously with 500 viablespecific staining of mast cells was performed using the Leder ester-
ase stain (Leder, 1979), as modified by Friend et al. (1996), and the third-stage N. brasiliensis larvae. Animals were sacrificed 5, 10, and
15 days postinfection, the intestinal worm burdens determined, andnumber of positively stained mast cells was counted per 3400 field
of view. serum taken. Jejunal tissue was removed and either snap frozen
for mast cell protease assay or processed for histology as describedBronchoalveolar lavage (BAL) fluids were collected by cannulating
the trachea and lavaging the lungs with a 1.0 ml of ice-cold PBS. above. In addition, mesenteric lymph node cells were harvested and
stimulated in vitro at either 2.5 3 106 cells per ml with plate-boundThe BAL cells were pelleted, washed, and counted. The numbers
of eosinophils, neutrophils, macrophages and lymphocytes was de- anti-CD3 or at 5 3 106 cells per ml with 50 mg/ml of parasite antigens
(NbES) (Lawrence et al., 1996) for 72 hr. Supernatants were har-termined by performing a differential count on at least 400 cells/
slide of Giemsa stained cytocentrifuge preparations. vested and analyzed for cytokines.
Immunity
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Total Serum Antibody ELISA sons from studies with rodent models. Annu. Rev. Immunol. 15,
505–533.Serum immunoglobulins were assayed using sandwich ELISA. 96-
well plates were coated with monoclonal antiimmunoglobulin iso- Foster, P., Hogan, S., Ramsay, A., Matthei, K., and Young, I. (1996).
type capture antibodies, and bound immunoglobulin of diluted Interleukin-5 deficiency abolishes eosinophilia, airways hyperreac-
serum samples was detected using biotinylated monoclonal antiim- tivity and lung damage in a mouse asthma model. J. Exp. Med. 183,
munoglobulin isotype detection antibodies (Becton Dickinson). Con- 195–201.
centrations were calculated using purified immunoglobulin isotypes
Frazer, K.A., Ueda, Y., Zhu, Y., Gifford, V.R., Garofalo, M.R., Mohan-
as standards (Becton Dickinson).
das, N., Martin, C.H., Palazzolo, M.J., Cheng, J.F., and Rubin, E.M.
(1997). Computational and biological analysis of 680 kb of DNA
Cytokine ELISA
sequence from the human 5q31 cytokine gene cluster. Genome Res.
Cytokine ELISA also utilized the sandwich format with capture and
7, 495–512.
detection antibodies purchased from Becton Dickinson. ELISA were
Friend, D.S., Ghildyal, N., Austen, K.F., Gurish, M.F., Matsumoto,performed according to Becton Dickinson ELISA protocol.
R., and Stevens, R.L. (1996). Mast cells that reside at different loca-
tions in the jejunum of mice infected with Trichinella spiralis exhibitMouse Mast Cell Protease-1 ELISA
sequential changes in their granule ultrastructure and chymase phe-Mouse mast cell protease-1 levels in jejunal homogenates were
notype. J. Cell Biol. 135, 279–290.assayed using a mMCP-1 ELISA kit purchased from Moredun Scien-
Galli, S.J., and Hammel, I. (1994). Mast cell and basophil develop-tific. ELISA was performed according to the manufacturer’s pro-
ment. Curr. Opin. Hematol. 1, 33–39.tocol.
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